Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Extrapyramidal side effects are unacceptable
Autore:
Kane, JM;
Indirizzi:
Hillside Hosp, Dept Psychiat, Glen Oaks, NY 11004 USA Hillside Hosp Glen Oaks NY USA 11004 pt Psychiat, Glen Oaks, NY 11004 USA
Titolo Testata:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
, volume: 11, anno: 2001, supplemento:, 4
pagine: 397 - 403
SICI:
0924-977X(200110)11:<397:ESEAU>2.0.ZU;2-4
Fonte:
ISI
Lingua:
ENG
Soggetto:
TARDIVE-DYSKINESIA; SCHIZOAFFECTIVE DISORDER; ACUTE EXACERBATION; FIRST EPISODE; DOUBLE-BLIND; LONG-TERM; SCHIZOPHRENIA; HALOPERIDOL; RISPERIDONE; RISK;
Keywords:
extrapyramidal side effects; tardive dyskinesia; schizophrenia; atypical antipsychotics;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
38
Recensione:
Indirizzi per estratti:
Indirizzo: Kane, JM Hillside Hosp, Dept Psychiat, 59-75 263rd St, Glen Oaks, NY 11004USA Hillside Hosp 59-75 263rd St Glen Oaks NY USA 11004 NY 11004 USA
Citazione:
J.M. Kane, "Extrapyramidal side effects are unacceptable", EUR NEUROPS, 11, 2001, pp. 397-403

Abstract

Extrapyramidal side effects (EPS) are a common and serious drawback to theuse of conventional antipsychotic drugs. In addition to the discomfort anddistress caused to patients, EPS may contribute to poor compliance and ultimately poor treatment outcome. The results of clinical trials with the newgeneration of atypical antipsychotics suggest that they are associated with a reduction in both early- and late-occurring EPS. All of the new-generation agents produce substantially fewer EPS, and reduce the need for antiparkinsonian medication, in comparison with haloperidol. Data from long-term studies suggest that new-generation antipsychotics are also associated with a reduced risk of tardive dyskinesia, particularly in the elderly. (C) 2001Elsevier Science BY. All rights reserved.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/20 alle ore 05:34:23